PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Renal-Electrolyte and Hypertension Division, Department of Medicine.\', \'Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.\', \'Department of Mathematics and Statistics, Wake Forest University.\', \'Department of Epidemiology and Prevention, Division of Public Health Sciences.\', \'Department of Biostatistics and Data Science, Division of Public Health Sciences.\', \'Section of Nephrology, Department of Pediatrics, Brenner Children\'s Hospital.\', \'Department of Surgery-Hypertension & Vascular Research.\', \'Cardiovascular Sciences Center, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/HJH.0000000000002706
?:hasPublicationType
?:journal
  • Journal of hypertension
is ?:pmid of
?:pmid
?:pmid
  • 33186321
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.733
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all